C

Cambridge Cancer Genomics

2 employees

Cambridge Cancer Genomics develops precision oncology solutions to transform the way cancer patients are treated.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Diagnostics
diagnostics
Health Care
therapy
Medical
cancer
machine learning
Artificial intelligence

Date founded

2017

Funding rounds raised

Total raised

$4.5M

from 11 investors over 11 rounds

C

Cambridge Cancer Genomics raised $4.5M on December 31, 2018

Investors: AME Cloud Ventures, Y Combinator, Romulus Capital, Soma Capital and Refactor Capital

C

Cambridge Cancer Genomics raised undisclosed on August 21, 2017

Investors: DTRIBE Capital, FundersClub and Y Combinator

C

Cambridge Cancer Genomics raised $4M on July 1, 2017

Investors: Pi Campus, NewDo Venture and Endure Capital

FAQ